327 event(s) found
Artificial Intelligence for Pediatric Hematology/Oncology: Innovations and Applications
Artificial Intelligence (AI) has many potential applications within clinical medicine; however, shortcomings of many AI-based tools limit our ability to use them in the "here and now." In this webinar, we will provide a brief primer on AI and discuss three user-ready AI-based tools you can use today to improve your productivity and efficiency in a clinical setting. We will discuss the use of AI-based ambient scribes to streamline documentation, review ways AI integration can enhance office productivity tools (e.g., word processing, email, videoconferencing), and discuss ways that general-purpose large language models can be used clinically.
EHA-EBMT 7th European CAR T-cell Meeting
The meeting covers a broad range of topics spanning the scientific and translational, clinical and commercial development in the field of CAR T. The program will bring you all the latest developments in CAR T cell therapy including previously unpublished clinical data, as well as progress in manufacturing, toxicity modeling, innovative CAR design, CAR delivery methods, and novel applications of CAR T-cell therapy. Join the meeting and have the chance to hear outstanding developments and network with your peers and renowned experts in the CAR T-cell therapy field.
6th SOHO Italy Annual Conference
The Italian Society of Hematologic Oncology is bringing together leading SOHO experts and top Italian researchers in acute leukemias, MPDs and MDSs, aims to consolidate the Italian Hematology- SOHO partnership. The aim of the association is the integration of the clinical-scientific activities of IRST Meldola and MD Anderson Cancer Center and the improvement of the clinical-therapeutic approach to patients with hematologic malignancies.
ELCC 2025
ELCC 2025 organized by IASLC
4th ICPO Forum: Advancing Theranostics in Precision Oncology
Over 220 experts from 27 countries will come together to shape the future of radiotheranostics for better cancer patient outcomes. This biannual conference will unite a broad spectrum of stakeholders – from academia, industry, patient advocacy groups and professional associations to investors and philanthropists. Forty international experts will share their insights on the global evolution of theranostics, latest advancements in education and accreditation, the growth of the ICPO Theranostics Centers network, as well as radiopharmaceutical game-changers and the role of artificial intelligence (AI).
EACR 2025 Annual Congress: Innovative Cancer Science
EACR 2025 Annual Congress: Innovative Cancer Science organized by EACR
18th ICML
The International Conference on Malignant Lymphoma (ICML) objectives and learning outcomes are: Acquaintance with the latest advances in basic science regarding lymphoma; Learning about the latest results of translational research into lymphoma; Information on the most recent data from clinical studies; Fostering discussion and sharing of ideas among attendees about innovations in the field of lymphoma; Spreading evidence-based knowledge of primary clinical relevance. The content of the Programme aims to: Provide information that is useful to the work of participants and relevant to practice techniques; Present well-balanced data supported by adequate evidence; Allow time for discussion and questions
2025 World Conference on Lung Cancer
2025 World Conference on Lung Cancer organized by IASLC
IMS 22nd Annual Meeting & Exposition
The International Myeloma Society Meeting is the defining annual meeting in myeloma with a focus on both the basic, preclinical, and clinical aspects. This year’s program includes: Four thematic sessions on: Precursor Disease Risk Adaptation Management Immunotherapy Relapse within 1-3 lines of therapy Talks and symposia on pressing topics led by the KOL of the myeloma community Keynote addresses Joint sessions with regulatory agencies and other organisations Meet the Expert sessions Oral Abstracts (on Basic Biology, Preclinical Trials, and Clinical Studies) Poster presentations and discussion sessions
Symposium Régional sur le Cancer du Sein
In French: "Une journée d'exception dédiée à la prise en charge du cancer du sein. Ce symposium a pour ambition de rassembler, à l'échelle régionale, l'ensemble des acteurs impliqués dans la lutte contre le cancer du sein, en favorisant des échanges pluridisciplinaires et inter-établissements, autour des données les plus récentes et des innovations majeures."
8th Translational Research Conference: Lymphoid Malignancies
This leading-edge translational research conference will address the rapidly evolving field of lymphoid malignancies, including T- and B-cell lymphomas, and chronic lymphocytic leukaemia (CLL), from molecular pathogenesis to state-of-the-art treatment and future perspectives.
Redefining the Finish Line: Late-Career Opportunities in Pediatric Hematology/Oncology
ASPHO webinars connect learners to the latest in Pediatric Hematology/Oncology clinical treatment, best practices, and professional development.
ACLC 2025
ACLC 2025 organized by IASLC
31ème Congrès du CHO (Club Hématopoïèse et Oncogenèse)
Le congrès du CHO est un événement scientifique important pour les chercheurs français du domaine de l’onco-hématologie et de l’hématopoïèse du fait de la présence d’orateurs prestigieux français et internationaux, principalement européens, qui acceptent de partager leurs travaux qui ne sont pas toujours publiés. Les jeunes étudiants/futurs chercheurs, présents majoritairement, l’utilisent comme une occasion de présenter leurs travaux avant la présentation à des congrès internationaux à l’étranger ou le départ vers un stage post-doctoral. Pour les jeunes chercheurs post-doctorants, ce congrès est aussi un lieu de (re)présentation devant la communauté scientifique française avant les concours pour des postes de chercheurs dans le secteur public (INSERM, CNRS, Universités). La présence croissante de jeunes français en post-doctorat, ou bien déjà en responsabilité à l’étranger, est observée, ces personnes venant présenter leurs travaux pour être connus, ou pour accroître leur visibilité auprès de la communauté scientifique française du domaine. C’est le lieu où jeunes chercheurs, jeunes cliniciens en formation et chercheurs confirmés français et internationaux du domaine peuvent interagir, entreprendre et discuter des collaborations en cours, ce congrès étant localisé sur un site géographique unique qui les accueille pendant 3 jours complets, nuit et jour. Un total de 165 personnes dont les orateurs invités ont été accueillies en 2024, et un nombre d’inscriptions similaire est attendu en 2025. Orateurs ayant confirmé leur venue pour 2025 : étrangers, Sean Morrison (USA), Ralf Adams (Allemagne), Allessandra Biffi (Italie), Jan Cools (Belgique), Alan J Warren (Angleterre), et Français, Lina Benajiba (Paris), Emmanuelle Clappier (Paris), Michèle Crozatier (Toulouse) et Xavier Morelli (Marseille).
Lymphoma, Leukemia & Myeloma Congress 2025
Celebrating 25 years of advancing blood cancer care — where global leaders unite to drive progress in leukemia, lymphoma, and myeloma treatment. Don't miss out on this exceptional and vibrant program that offers four days of in-depth learning. Join us as we delve into emerging data, explore innovative treatment methods, and catch a glimpse of what the future holds for lymphoma, leukemia, and myeloma disorders.
20th Meeting of the European Association of Neuro-Oncology (EANO 2025)
20th Meeting of the European Association of Neuro-Oncology (EANO 2025) organized by EANO
SIOP 2025
The International Society of Paediatric Oncology (SIOP) was established on November 6, 1969, by a small group of specialists at the Institut Gustave-Roussy in Paris, with the mission to advance the study and care of children with cancer. This goal was expanded to include the advancement of basic research as well as clinical studies, the inclusion of nurses, other health professionals and parents, and the organization of teaching and outreach programs to improve childhood cancer care in underdeveloped communities. Today, SIOP is a truly global, multifaceted organization and is the only global multidisciplinary society entirely devoted to paediatric and adolescent cancer. The Society has over 3,000 members worldwide including doctors, nurses, allied healthcare professionals, scientists and researchers etc. Our members are dedicated to increasing knowledge about all aspects of childhood cancer.
iMig 2025
The theme for iMig 2025 is “Fostering Global Collaboration.” In addition to the traditional well-balanced presentations from the top international experts and the most exciting cutting-edge research that has come to be the hallmark of iMig conferences, this year we will be doing something new. Beyond the usual informal networking that makes iMig one of the most anticipated and productive cancer conferences in the world, this year all attendees will be invited to join in a structured networking session each day of the conference, culminating in the generation of two international collaborations – one translational research project and one clinical trial. This iMig will conclude with the Keynote address by Dr. Stephen Hahn on the art of the possible that can be achieved working as a team. Dr. Hahn, internationally acclaimed radiation oncologist and researcher, served as the Director of the FDA during the height of the pandemic and managed the team effort that resulted in production of the life-saving COVID vaccine in record time. This address will be followed by presentation of the two teamwork projects generated at the 2025 iMig and will lay the path forward for attendees to participate in these projects.
APHON-Sponsored Virtual Chemotherapy and Biotherapy Provider Course
The Pediatric Chemotherapy and Biotherapy Provider Course is a 2-day course is designed for license nurses who are new to pediatric and adolescent chemotherapy and biotherapy administration, as well as for those who want a comprehensive review. The Pediatric Chemotherapy Biotherapy Curriculum 4th Edition is the required textbook for all Chemotherapy/Biotherapy Provider Courses.
16th World ADC San Diego
As antibody-drug conjugates aspire to advance to earlier-line treatments, harnessing innovation has never been more important to redefine the oncology standard of care and provide long-term benefit to patients. Returned as the annual touchpoint for the global community, the 16th World ADC San Diego is the week to fully immerse yourself in all things antibody-drug conjugate, spotlighting the cutting-edge innovation empowering the industry to develop differentiated ADCs that show clear advantages against standard-of-care therapies with clinically meaningful patient benefit. With 7 streams of end-to-end content spanning discovery chemistry, discovery biology, preclinical, translational medicine, clinical lessons, process and analytical development, and manufacturing and supply chain: this is your one-stop bioconjugate shop to bring your team up to speed with ADC fundamentals, get answers to the problems hindering your ADC R&D, and identify emerging trends to ensure you stay ahead of the curve. Providing unparalleled networking opportunities with 1,400+ attendees from start-ups, biotechs, large pharma and leading service providers, anybody who is anybody in the ADC field united under one roof to innovate, collaborate, and redefine the standard of oncology care.
SITC 2025 (40th Anniversary)
Advancing the Science and Application of Cancer Immunotherapy Worldwide Make your mark at the largest cancer immunotherapy conference and exhibit at SITC’s 40th Anniversary Annual Meeting, hosted by the leading member-driven organization focused on cancer immunotherapy, SITC. At SITC’s Annual Meeting, we will bring together international leaders from academia, regulatory and government agencies, as well as industry representatives for unmatched education, scientific exchange and networking with the scientists driving the field.
SITC Town Hall Webinar: The State of Play in Immunotherapy Research
The Society for Immunotherapy of Cancer (SITC) is pleased to offer the first FREE MEMBER-ONLY webinar in the SITC Town Hall live webinar series, "SITC Town Hall: The State of Play in Immunotherapy Research". Webinar Description: For 40 years, SITC has been the leader in promoting tumor immunology and advancing cancer immunotherapy research and education. Considering that recent federal actions have posed challenges to the biomedical research landscape, we believe it is essential to unite our community to exchange knowledge and share experiences. In addition to facilitating these discussions, SITC is implementing several precautionary measures to safeguard privacy, including prohibiting the recording or distribution of webinars, Q&A anonymity, and enforcing a more secure registration process. Key leaders in the field who are experts in their respective fields will provide an overview of the current state of the science and address questions about its future.
Congrès SFI Paris 2025
La Société Française d’Immunologie (SFI) vous donne rendez-vous du 12 au 14 novembre 2025 à la Cité des Sciences et de l’Industrie (Porte de la Villette, Paris) pour son congrès annuel. Cet événement réunira la communauté des immunologistes autour des dernières avancées en immunologie fondamentale, appliquée et médicale.
ITCC Annual Meeting 2025
The annual meeting of the Innovative Therapies for Children and Adolescents with Cancer (ITCC) consortium